Schizoaffective Disorders Recruiting Phase 4 Trials for Memantine (DB01043)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Recruiting4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03860597Memantine Effects on Sensorimotor Gating and Neurocognition in SchizophreniaSupportive Care